OBJECTIVES: Recent large cholera outbreaks highlight the need for improved understanding of the pathogenesis and epidemiology of cholera. The incubation period of cholera has important implications for clinical and public health decision-making, yet statements of the incubation period of cholera are often imprecise. Here we characterize the distribution of cholera's incubation period. METHODS: We conducted a systematic review of the literature for statements of the incubation period of cholera and data that might aid in its estimation. We extracted individual-level data, parametrically estimated the distribution of toxigenic cholera's incubation period, and evaluated evidence for differences between strains. RESULTS: The incubation period did not differ by a clinically significant margin between strains (except O1 El Tor Ogawa). We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection. CONCLUSIONS: We recommend that cholera investigations use a recall period of at least five days to capture relevant exposures; significantly longer than recent risk factor studies from the Haitian epidemic. This characterization of cholera's incubation period can help improve clinical and public health practice and advance epidemiologic research.
OBJECTIVES: Recent large cholera outbreaks highlight the need for improved understanding of the pathogenesis and epidemiology of cholera. The incubation period of cholera has important implications for clinical and public health decision-making, yet statements of the incubation period of cholera are often imprecise. Here we characterize the distribution of cholera's incubation period. METHODS: We conducted a systematic review of the literature for statements of the incubation period of cholera and data that might aid in its estimation. We extracted individual-level data, parametrically estimated the distribution of toxigenic cholera's incubation period, and evaluated evidence for differences between strains. RESULTS: The incubation period did not differ by a clinically significant margin between strains (except O1 El Tor Ogawa). We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection. CONCLUSIONS: We recommend that cholera investigations use a recall period of at least five days to capture relevant exposures; significantly longer than recent risk factor studies from the Haitian epidemic. This characterization of cholera's incubation period can help improve clinical and public health practice and advance epidemiologic research.
Authors: M M Levine; D R Nalin; J P Craig; D Hoover; E J Bergquist; D Waterman; H P Holley; R B Hornick; N P Pierce; J P Libonati Journal: Trans R Soc Trop Med Hyg Date: 1979 Impact factor: 2.184
Authors: M B Cohen; R A Giannella; G A Losonsky; D R Lang; S Parker; J A Hawkins; C Gunther; G A Schiff Journal: Infect Immun Date: 1999-12 Impact factor: 3.441
Authors: J L Taylor; J Tuttle; T Pramukul; K O'Brien; T J Barrett; B Jolbitado; Y L Lim; D Vugia; J G Morris; R V Tauxe Journal: J Infect Dis Date: 1993-06 Impact factor: 5.226
Authors: Stacie E Dunkle; Adamma Mba-Jonas; Anagha Loharikar; Bernadette Fouché; Mireille Peck; Tracy Ayers; W Roodly Archer; Valery M Beau De Rochars; Thomas Bender; Daphne B Moffett; Jordan W Tappero; George Dahourou; Thierry Roels; Robert Quick Journal: Emerg Infect Dis Date: 2011-11 Impact factor: 6.883
Authors: Theresa L Rager; Cristian Koepfli; Wasif A Khan; Sabeena Ahmed; Zahid Hayat Mahmud; Katherine N Clayton Journal: J Med Internet Res Date: 2021-05-12 Impact factor: 5.428
Authors: Rebecca Kahn; Corey M Peak; Juan Fernández-Gracia; Alexandra Hill; Amara Jambai; Louisa Ganda; Marcia C Castro; Caroline O Buckee Journal: Proc Natl Acad Sci U S A Date: 2020-02-13 Impact factor: 11.205
Authors: Troy P Hubbard; Gabriel Billings; Tobias Dörr; Brandon Sit; Alyson R Warr; Carole J Kuehl; Minsik Kim; Fernanda Delgado; John J Mekalanos; Joseph A Lewnard; Matthew K Waldor Journal: Sci Transl Med Date: 2018-06-13 Impact factor: 17.956
Authors: Andrew S Azman; Francisco J Luquero; Iza Ciglenecki; Rebecca F Grais; David A Sack; Justin Lessler Journal: PLoS Med Date: 2015-08-25 Impact factor: 11.069